Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
Recruiting · NCT05395624 · Registry updated 2025-05-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers | Alzheimer disease, CNS demyelinating autoimmune disease, Nutritional and Metabolic Diseases, Parkinson disease, TDP-43 proteinopathy, amyotrophic lateral sclerosis, autoimmune disease, autoimmune disorder of the nervous system, basal ganglia disorder, brain disorder, central nervous system disorder, cognitive disorder, dementia, demyelinating disease, immune system disorder, metabolic disease, motor neuron disorder, movement disorder, multiple sclerosis, nervous system disorder, neurodegenerative disease, neuromuscular disease, parkinsonian disorder, proteostasis deficiencies, psychiatric disorder, spinal cord disorder, synucleinopathy, tauopathy | Recruiting | Phase 1 / Phase 2 | 2025-05-02 | NCT05395624 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ashvattha Therapeutics, Inc. | 3 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Mayo Clinic Jacksonville | Jacksonville | United States | 67 |
| Stanford University | Stanford | United States | 213 |
| UCSF | San Francisco | United States | 2 |